These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19268138)

  • 21. Overcoming or circumventing the stratum corneum barrier for efficient transcutaneous immunization.
    Chen Z; Lv Y; Qi J; Zhu Q; Lu Y; Wu W
    Drug Discov Today; 2018 Jan; 23(1):181-186. PubMed ID: 28988995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
    Cryz SJ; Glück R
    Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
    Herzog C
    Expert Rev Vaccines; 2014 Mar; 13(3):399-415. PubMed ID: 24512188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colloidal carrier systems for transcutaneous immunization.
    Gupta PN; Vyas SP
    Curr Drug Targets; 2011 Apr; 12(4):579-97. PubMed ID: 21226670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacies of inactivated vaccines against betanodavirus in grouper larvae (Epinephelus coioides) by bath immunization.
    Kai YH; Chi SC
    Vaccine; 2008 Mar; 26(11):1450-7. PubMed ID: 18276044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes.
    Tsals I; Jarrahian C; Snyder FE; Saganic L; Saxon E; Zehrung D; Zimmerman G; Papania M; Klaff L
    Vaccine; 2015 Sep; 33(37):4705-11. PubMed ID: 25964169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA vaccines and intradermal vaccination by DNA tattooing.
    Oosterhuis K; van den Berg JH; Schumacher TN; Haanen JB
    Curr Top Microbiol Immunol; 2012; 351():221-50. PubMed ID: 21107792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New emerging technologies and the intradermal route: the novel way to immunize against influenza.
    Falsey AR
    Vaccine; 2010 Sep; 28 Suppl 4():D24-32. PubMed ID: 20713257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines.
    Potthoff A; Schwannecke S; Nabi G; Hoffmann D; Grunwald T; Wildner O; Brockmeyer NH; Uberla K; Tenbusch M
    Vaccine; 2009 May; 27(21):2768-74. PubMed ID: 19366575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.
    Kouiavskaia D; Mirochnitchenko O; Dragunsky E; Kochba E; Levin Y; Troy S; Chumakov K
    J Infect Dis; 2015 May; 211(9):1447-50. PubMed ID: 25391313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protective action of liposome-incorporated surface antigens of the influenza virus by different methods of immunization].
    Burkhanov SA; Mazhul' LA; Torchilin VP; Ageeva ON; Saatov TS
    Vopr Virusol; 1988; 33(2):151-3. PubMed ID: 3414063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
    Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P
    Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sizing the optimal dimensions of a vaccine delivery system: a particulate matter.
    Slütter B; Jiskoot W
    Expert Opin Drug Deliv; 2016; 13(2):167-70. PubMed ID: 26578092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel vaccine approaches.
    Woodland DL
    Viral Immunol; 2013 Feb; 26(1):1-2. PubMed ID: 23409928
    [No Abstract]   [Full Text] [Related]  

  • 37. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
    Teunissen MB; Haniffa M; Collin MP
    Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal immunization using coated microneedles containing an immunoadjuvant.
    Andrianov AK; Mutwiri G
    Vaccine; 2012 Jun; 30(29):4355-60. PubMed ID: 22682291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behaviour of the typhoid vaccine intradermally administered in association with tetanus unadsorbed vaccine and soluble antigens of vaccinia virus.
    Croitoru M; Dimache G; Mihăilescu R; Velea V; Durbacă S; Stoean C
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):139-43. PubMed ID: 3250365
    [No Abstract]   [Full Text] [Related]  

  • 40. Usability evaluation of intradermal adapters (IDA).
    Tsals I
    Vaccine; 2017 Mar; 35(14):1797-1801. PubMed ID: 27496277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.